Antipodes Partners’s Endava DAVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DAVA
PGCM
PIM
CU
AIMCA
KA
RG
Antipodes Partners's DAVA Position: Q2 2026 in Review
Antipodes Partners increased its Endava (DAVA) stake by 0.46% in Q2 2026, buying an estimated $2.25K and bringing the position to 132,710 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #93.
Antipodes Partners first reported a position in DAVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $584K in Q1 2026. 72 funds tracked by Wall St. Rank hold DAVA as of Q2 2026.
- Antipodes Partners held 132,710 shares of Endava worth $376K as of Q2 2026.
- Antipodes Partners bought 609 Endava shares in Q2 2026, an estimated $2.25K.
- Endava made up 0.01% of Antipodes Partners's portfolio in Q2 2026, its #93 holding.
- Antipodes Partners first reported a position in Endava in Q1 2026 and has held it in 2 quarters since.
- Antipodes Partners's Endava position peaked at $584K in Q1 2026.
- 72 funds tracked by Wall St. Rank held Endava as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.